Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-02-003192
Filing Date
2002-04-01
Accepted
2002-04-01 00:00:00
Documents
4
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 KING PHARMACEUTICALS, INC. g74870e10-k.txt 10-K 421776
3 SUBSIDIARIES OF THE REGISTRANT g74870ex21-1.txt EX-21.1 700
4 CONSENT OF PRICEWATERHOUSECOOPERS LLP g74870ex23-1.txt EX-23.1 666
5 CONSENT OF ERNST & YOUNG LLP g74870ex23-2.txt EX-23.2 1100
  Complete submission text file 0000950144-02-003192.txt   426081
Mailing Address 501 FIFTH ST BRISTOL TN 37620
Business Address 501 FIFTH ST BRISTOL TN 37620 4239898000
KING PHARMACEUTICALS INC (Filer) CIK: 0001047699 (see all company filings)

EIN.: 541684963 | State of Incorp.: TN | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15875 | Film No.: 02595352
SIC: 2834 Pharmaceutical Preparations